Skip to main content

Jill M. Broadfoot

Equibles does not estimate personal net worth.

Get an email with a short summary when Talphera, Inc. publishes a filing, an earnings call transcript or a press release.

Get TLPH alerts

About Jill M. Broadfoot

Jill M. Broadfoot is recorded as Board Member at Talphera, Inc. (TLPH) since November 20, 2021. Talphera, Inc. reported in an 8-K filed November 23, 2021 that Jill M. Broadfoot was appointed Class I director of the Board, effective November 20, 2021. Talphera, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Talphera, Inc. includes Vincent J. Angotti (CEO and Board Member), Raffi Asadorian (CFO), Abhinav Jain (Board Member) and 7 others.

“On November 20, 2021, the Board of Directors (the “Board”) of AcelRx Pharmaceuticals, Inc. (the “Company”) appointed Jill M. Broadfoot a Class I director of the Board, effective November 20, 2021, to serve until the expiration of her term at the 2024 annual meeting of stockholders.”
Talphera, Inc. Form 8-K, filed November 23, 2021 · Read the filing

Affiliation history

Company network

Current role

Drug Manufacturers - Specialty & Generic · Healthcare

Board Member

2021-11-20–present

Leadership on record at Talphera, Inc.

Recent activity